Privia Health Group (NASDAQ:PRVA – Free Report) had its price objective increased by Truist Financial from $27.00 to $28.00 in a report issued on Thursday,Benzinga reports. The firm currently has a buy rating on the stock.
Several other analysts also recently weighed in on PRVA. Canaccord Genuity Group boosted their price target on Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, February 28th. Needham & Company LLC reiterated a “buy” rating and issued a $30.00 target price on shares of Privia Health Group in a research report on Friday, March 21st. Piper Sandler raised their price target on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a research report on Friday, February 28th. Stephens reaffirmed an “overweight” rating and issued a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. Finally, Macquarie started coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 price objective on the stock. One analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Buy” and an average target price of $26.87.
View Our Latest Stock Analysis on PRVA
Privia Health Group Trading Up 1.9 %
Insider Activity at Privia Health Group
In related news, CFO David Mountcastle sold 5,630 shares of Privia Health Group stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the sale, the chief financial officer now owns 179,676 shares of the company’s stock, valued at approximately $4,021,148.88. This trade represents a 3.04 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 14.20% of the stock is owned by company insiders.
Hedge Funds Weigh In On Privia Health Group
Several hedge funds and other institutional investors have recently added to or reduced their stakes in PRVA. First Horizon Advisors Inc. raised its position in shares of Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after purchasing an additional 632 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after buying an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. acquired a new position in shares of Privia Health Group during the fourth quarter valued at approximately $51,000. Neo Ivy Capital Management purchased a new position in shares of Privia Health Group in the third quarter valued at approximately $66,000. Finally, Quadrant Capital Group LLC boosted its stake in shares of Privia Health Group by 11.8% in the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock worth $95,000 after acquiring an additional 511 shares during the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.
Privia Health Group Company Profile
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
See Also
- Five stocks we like better than Privia Health Group
- What is diluted earnings per share (Diluted EPS)?
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- What Are Treasury Bonds?
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- Best Stocks Under $10.00
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.